Abstract
Autoimmune diseases can affect the lungs, and the mechanisms used to prevent autoimmune lung disease are incompletely understood. Recent studies in the thymus have identified unique populations of medullary thymic epithelial cells (mTECs) called mimetic cells that transcriptionally mimic peripheral epithelial populations. These mimetic cells have important functions in the thymus in immune tolerance. Here, we used a mouse line with thymic-specific deletion of Runt-related transcription factor 1 (Runx1) to identify a new mimetic cell akin to alveolar type 2 (AT2) lung epithelial cells. AT2 mTECs express surfactant genes, and with Runx1 deletion AT2 mTECs expand, resulting in a loss of AIRE+ mTECs and defects in T cell selection. RUNX1 suppresses AT2 mTECs by inhibiting epidermal growth factor receptor signaling. Together, our results identify a thymic mimetic cell type that mimics lung AT2 epithelial cells, further uncovering unrealized epithelial diversity in the thymus.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout







Similar content being viewed by others
Data availability
All newly generated genomics data, including CUT&RUN data and scRNA-seq data, have been deposited at the NCBI GEO Database and are available under accession numbers GSE290143 (CUT&RUN) and GSE290144 (scRNA-seq). Previously reported data are available from GEO under accession numbers GSE226493, GSE1460657, GSE144877, GSE194253, GSE147520, GSE267785 and GSE140654. The PhIP–seq data are available at the Dryad Digital Repository under accession IDs Q66H4FM2 and Q6BG2M7B. Source data are provided with this paper.
Code availability
All code is available at GitHub at https://github.com/j-germino/Runx1-integration and https://github.com/jhsin/scRNA-seq-re-analysis-of-aged-thymus.
References
Abramson, J. & Anderson, G. Thymic epithelial cells. Annu. Rev. Immunol. 35, 85–118 (2017).
Derbinski, J., Schulte, A., Kyewski, B. & Klein, L. Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self. Nat. Immunol. 2, 1032–1039 (2001).
Anderson, M. S. et al. Projection of an immunological self shadow within the thymus by the AIRE protein. Science 298, 1395–1401 (2002).
Takaba, H. et al. FEZF2 orchestrates a thymic program of self-antigen expression for immune tolerance. Cell 163, 975–987 (2015).
Nagamine, K. et al. Positional cloning of the APECED gene. Nat. Genet. 17, 393–398 (1997).
Wells, K. L. et al. Combined transient ablation and single-cell RNA-sequencing reveals the development of medullary thymic epithelial cells. eLife 9, e60188 (2020).
Ohigashi, I. et al. Developmental conversion of thymocyte-attracting cells into self-antigen-displaying cells in embryonic thymus medulla epithelium. eLife 12, RP92552 (2024).
Givony, T. et al. Thymic mimetic cells function beyond self-tolerance. Nature 622, 164–172 (2023).
Michelson, D. A., Hase, K., Kaisho, T., Benoist, C. & Mathis, D. Thymic epithelial cells co-opt lineage-defining transcription factors to eliminate autoreactive T cells. Cell 185, 2542–2558 (2022).
Miller, C. N. et al. Thymic tuft cells promote an IL-4-enriched medulla and shape thymocyte development. Nature 559, 627–631 (2018).
Mevel, R., Draper, J. E., Lie, A. L. M., Kouskoff, V. & Lacaud, G. RUNX transcription factors: orchestrators of development. Development 146, dev148296 (2019).
Tober, J., Yzaguirre, A. D., Piwarzyk, E. & Speck, N. A. Distinct temporal requirements for RUNX1 in hematopoietic progenitors and stem cells. Development 140, 3765–3776 (2013).
Gordon, J. et al. Specific expression of lacZ and cre recombinase in fetal thymic epithelial cells by multiplex gene targeting at the Foxn1 locus. BMC Dev. Biol. 7, 69 (2007).
Sin, J. H. et al. Ikaros is a principal regulator of AIRE+ mTEC homeostasis, thymic mimetic cell diversity, and central tolerance. Sci. Immunol. 8, eabq3109 (2023).
Bautista, J. L. et al. Single-cell transcriptional profiling of human thymic stroma uncovers novel cellular heterogeneity in the thymic medulla. Nat. Commun. 12, 1096 (2021).
Little, D. R. et al. Differential chromatin binding of the lung lineage transcription factor NKX2-1 resolves opposing murine alveolar cell fates in vivo. Nat. Commun. 12, 2509 (2021).
Mason, R. J. Biology of alveolar type II cells. Respirology 11, S12–S15 (2006).
Zhang, Z. et al. Transcription factor ETV5 is essential for the maintenance of alveolar type II cells. Proc. Natl Acad. Sci. USA 114, 3903–3908 (2017).
Schneider, J. P. et al. On the topological complexity of human alveolar epithelial type 1 cells. Am. J. Respir. Crit. Care Med. 199, 1153–1156 (2019).
Reyes, N. S. et al. Sentinel p16(INK4a+) cells in the basement membrane form a reparative niche in the lung. Science 378, 192–201 (2022).
Vanderbilt, J. N. et al. High-efficiency type II cell-enhanced green fluorescent protein expression facilitates cellular identification, tracking, and isolation. Am. J. Respir. Cell Mol. Biol. 53, 14–21 (2015).
Desai, T. J., Brownfield, D. G. & Krasnow, M. A. Alveolar progenitor and stem cells in lung development, renewal and cancer. Nature 507, 190–194 (2014).
Treutlein, B. et al. Reconstructing lineage hierarchies of the distal lung epithelium using single-cell RNA-seq. Nature 509, 371–375 (2014).
Chen, S. C. et al. Impaired pulmonary host defense in mice lacking expression of the CXC chemokine lungkine. J. Immunol. 166, 3362–3368 (2001).
Lucas, B. et al. Diversity in medullary thymic epithelial cells controls the activity and availability of iNKT cells. Nat. Commun. 11, 2198 (2020).
Breed, E. R., Watanabe, M. & Hogquist, K. A. Measuring thymic clonal deletion at the population level. J. Immunol. 202, 3226–3233 (2019).
Tomofuji, Y. et al. CHD4 choreographs self-antigen expression for central immune tolerance. Nat. Immunol. 21, 892–901 (2020).
Rackaityte, E. et al. Validation of a murine proteome-wide phage display library for identification of autoantibody specificities. JCI Insight 8, e174976 (2023).
Vazquez, S. E. et al. Autoantibody discovery across monogenic, acquired, and COVID-19-associated autoimmunity with scalable PhIP–seq. eLife 11, e78550 (2022).
Jiang, W., Anderson, M. S., Bronson, R., Mathis, D. & Benoist, C. Modifier loci condition autoimmunity provoked by AIRE deficiency. J. Exp. Med. 202, 805–815 (2005).
Sharifinejad, N. et al. Clinical, immunological, and genetic features in 938 patients with autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED): a systematic review. Expert Rev. Clin. Immunol. 17, 807–817 (2021).
Machanick, P. & Bailey, T. L. MEME-ChIP: motif analysis of large DNA datasets. Bioinformatics 27, 1696–1697 (2011).
Zhou, Y. et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat. Commun. 10, 1523 (2019).
Shinohara, T. & Honjo, T. Epidermal growth factor can replace thymic mesenchyme in induction of embryonic thymus morphogenesis in vitro. Eur. J. Immunol. 26, 747–752 (1996).
Satoh, R. et al. Requirement of STAT3 signaling in the postnatal development of thymic medullary epithelial cells. PLoS Genet. 12, e1005776 (2016).
Nabhan, A. N., Brownfield, D. G., Harbury, P. B., Krasnow, M. A. & Desai, T. J. Single-cell WNT signaling niches maintain stemness of alveolar type 2 cells. Science 359, 1118–1123 (2018).
Nava, M. et al. Transcriptomic and ChIP-sequence interrogation of EGFR signaling in HER2+ breast cancer cells reveals a dynamic chromatin landscape and S100 genes as targets. BMC Med. Genomics 12, 32 (2019).
Jung, H. et al. An ILC2-chitinase circuit restores lung homeostasis after epithelial injury. Sci. Immunol. 9, eadl2986 (2024).
Wee, P. & Wang, Z. Epidermal growth factor receptor cell proliferation signaling pathways. Cancers 9, 52 (2017).
Mohammadhosseini, M. et al. Targeting the CD74 signaling axis suppresses inflammation and rescues defective hematopoiesis in RUNX1-familial platelet disorder. Sci. Transl. Med. 17, eadn9832 (2025).
Kang, S. W. et al. Insulin-like growth factor 2 as a driving force for exponential expansion and differentiation of the neonatal thymus. Development 152, dev204347 (2025).
Jenkinson, W. E., Jenkinson, E. J. & Anderson, G. Differential requirement for mesenchyme in the proliferation and maturation of thymic epithelial progenitors. J. Exp. Med. 198, 325–332 (2003).
Akiyama, T. et al. The tumor necrosis factor family receptors RANK and CD40 cooperatively establish the thymic medullary microenvironment and self-tolerance. Immunity 29, 423–437 (2008).
Li, L. et al. Janus kinase inhibitor ruxolitinib blocks thymic regeneration after acute thymus injury. Biochem. Pharmacol. 171, 113712 (2020).
Brownfield, D. G. et al. Alveolar cell fate selection and lifelong maintenance of AT2 cells by FGF signaling. Nat. Commun. 13, 7137 (2022).
Wu, T. et al. mTOR masters monocytic myeloid-derived suppressor cells in mice with allografts or tumors. Sci Rep. 6, 20250 (2016).
O’Sullivan, C., Lewis, C. E., Harris, A. L. & McGee, J. O. Secretion of epidermal growth factor by macrophages associated with breast carcinoma. Lancet 342, 148–149 (1993).
Sansom, S. N. et al. Population and single-cell genomics reveal the AIRE dependency, relief from Polycomb silencing, and distribution of self-antigen expression in thymic epithelia. Genome Res. 24, 1918–1931 (2014).
Sinnberg, T. et al. Pulmonary surfactant proteins are inhibited by immunoglobulin A autoantibodies in severe COVID-19. Am. J. Respir. Crit. Care Med. 207, 38–49 (2023).
Wyss, N. et al. Autoimmunity against surfactant protein B is associated with pneumonitis during checkpoint blockade. Am. J. Respir. Crit. Care Med. 210, 919–930 (2024).
Heizmann, B., Kastner, P. & Chan, S. Ikaros is absolutely required for pre-B cell differentiation by attenuating IL-7 signals. J. Exp. Med. 210, 2823–2832 (2013).
Madisen, L. et al. A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat. Neurosci. 13, 133–140 (2010).
Metzger, T. C. et al. Lineage tracing and cell ablation identify a post-AIRE-expressing thymic epithelial cell population. Cell Rep. 5, 166–179 (2013).
Su, M. A. et al. Mechanisms of an autoimmunity syndrome in mice caused by a dominant mutation in AIRE. J. Clin. Invest. 118, 1712–1726 (2008).
Lopez, R., Regier, J., Cole, M. B., Jordan, M. I. & Yosef, N. Deep generative modeling for single-cell transcriptomics. Nat. Methods 15, 1053–1058 (2018).
Wolf, F. A., Angerer, P. & Theis, F. J. SCANPY: large-scale single-cell gene expression data analysis. Genome Biol. 19, 15 (2018).
Park, J. E. et al. A cell atlas of human thymic development defines T cell repertoire formation. Science 367, eaay3224 (2020).
Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357–359 (2012).
Li, H. et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 25, 2078–2079 (2009).
Quinlan, A. R. & Hall, I. M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841–842 (2010).
Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15–21 (2013).
Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).
Vazquez, S. E. et al. Identification of novel, clinically correlated autoantigens in the monogenic autoimmune syndrome APS1 by proteome-wide PhIP–seq. eLife 9, e55053 (2020).
Acknowledgements
Flow cytometry was performed at the UCSF Parnassus Flow Core, and high-throughput sequencing was performed at the UCSF Functional Genomics Core Facility. This work was supported by NIH grant R01AI165829 (to M.R.W.), a UCSF REAC award (M.R.W.) and the UCSF Parnassus Flow Core (RRID:SCR_018206, supported by NIH P30DK063720).
Author information
Authors and Affiliations
Contributions
J.H.S. and M.R.W. conceived the study, performed experiments, analyzed data and wrote the manuscript. C.J.B. assisted with CUT&RUN. J.G. assisted with scRNA-seq data analysis. S.H.P., J.S. and M.S.A. assisted with data analysis and manuscript preparation. A.B. assisted with PhIP–seq analysis. X.L., C.N.M. and Y.W. assisted with AIRE-deficient scRNA-seq. A.V.P. assisted with human scRNA-seq analysis.
Corresponding author
Ethics declarations
Competing interests
Y.W. is employed by 10x Genomics. The other authors declare no competing interests.
Peer review
Peer review information
Nature Immunology thanks the anonymous reviewer(s) for their contribution to the peer review of this work. Peer reviewer reports are available. Primary Handling Editor: L. A. Dempsey, in collaboration with the rest of the Nature Immunology team.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Extended data
Extended Data Fig. 1 Runx1 transcript is expressed in MHC-IIlow mTECs.
a, Relative expression of Runx1 mRNA in stromal cells. Downloaded from the Immgen expression database. b, qPCR of Runx1 gene expression in sorted MHC-IIhigh and MHC-IIlow mTECs and Ly51+ cTECs from Foxn1-Cre (-)/Runx1fl/fl (Cre(-)) and Foxn1-Cre(+)/Runx1fl/fl (Cre(+)) mice. c, qPCR of Runx1 gene expression in sorted single positive (SP) CD4+ thymocytes, SP CD8+ thymocytes, double positive (DP) CD4+/CD8+ thymocytes, splenic CD4+ T cells, splenic CD8+ T cells, and splenic CD19+ B cells. d, Confocal microscopy of cytokeratin 5 (KRT5) (red) and cytokeratin 8 (KRT8) (green) from 30-day old thymi. Images taken at 63X magnification. Scale bars = 5 μm. Data are representative of three independent experiments. e, Flow cytometry (left) and percentage (right) of MHC-IIhigh cTECs gated on CD11c−/CD45−/EpCAM+/Ly51+/UEA-1−/IAb+ TECs (n = 5 mice; two independent experiments). f, Flow cytometry (left) and percentage (right) of Ki67+ cTECs gated on CD11c−/CD45−/EpCAM+/Ly51+/Ki67+ TECs (n = 5 mice; two independent experiments). g, Flow cytometry and percentage/absolute number of positively selected T cells gated on TCRβ and CD69 (n = 3 Cre(-) and n = 5 Cre(+) mice; two independent experiments). (e-g) In graphs, the bars correspond to the mean, with error bars showing ±SD of values shown, and each data point represents an individual mouse. (e-g) P values by unpaired two-tailed t-test.
Extended Data Fig. 2 Runx1-deletion in TECs does not alter thymic tuft cells.
a, Confocal microscopy of cytokeratin 5 (KRT5) (red), Aire (green), and DAPI (blue) of 30-day old thymi from Foxn1-Cre (-)/Runx1fl/fl (Cre(-)) and Foxn1-Cre(+)/Runx1fl/fl (Cre(+)) mice. Images taken at 20X magnification and scale bar = 25 μm. Inserts taken at 200X magnification and scale bar 5 μm. b-c, Flow cytometry (left) and percentage and absolute number (right) of Ki67+ mTECs gated on CD11c−/CD45−/EpCAM+/Ly51−/IAb+ TECs (b) or Ki67+/Aire+ mTECs gated on CD11c−/CD45−/EpCAM+/Ly51−/IAb+/Aire+ mTECs (c) (n = 6 mice; two independent experiments). d, Flow cytometry (left) and percentage and absolute number (right) of Apotracker+ mTECs gated on CD11c−/CD45−/EpCAM+/Ly51−/IAb+ mTECs (n = 4 mice; two independent experiments). e-f, Flow cytometry (left) and percentage and absolute number (right) of DCLK1+ thymic tufts cells (e), L1CAM+ thymic tufts cells (f) gated on CD11c−/CD45−/EpCAM+/Ly51−/IAb+ TECs (n = 3 (e) and n = 4 (f) mice; (e) representative experiment, and (f) two independent experiments). g, Confocal microscopy of cytokeratin 10 (KRT10) (red), DCLK1 (green), and DAPI (blue) of 30-day old thymi. Images taken at 20X magnification. Scale bars = 25 μm. (b-f) In graphs, the bars correspond to the mean, with error bars showing ±SD of values shown, and each data point represents an individual mouse. (b-f) P values by unpaired two-tailed t-test. (a,g) Data are representative of three independent experiments.
Extended Data Fig. 3 RUNX1 is expressed in human mTECs.
a-b, UMAPs (a) and violin plots (b) of marker genes from scRNA-seq data from sorted CD11c−/EpCAM+/Ly51− mTECs. c-d, scRNA-seq of human thymic epithelial cells. UMAP of human mTEC clusters and RUNX1 expression (c). Violin plot of RUNX1 expression (d). e, UMAP of scRNA-seq of MHC-IIlow mTECs from C57BL/6 mice merged with scRNA-seq from Foxn1-Cre(+)/Runx1+/+ mTECs to identify AT2 mTEC. Red numbers are the percentage of AT2 mTECs.
Extended Data Fig. 4 scRNA-seq analysis of Lung AT2 and AT2 mTECs.
a, UMAPs of cell distributions from lung scRNA-seq and Foxn1-Cre(+)/Runx1fl/fl mTECs scRNA-seq. b-c, Heatmap (b) and UMAPs (c) showing characteristic marker genes from populations in (a). d-e, Metascape analysis of differentially expressed genes between AT2 mTEC and Lung AT2.
Extended Data Fig. 5 Runx1-deletion results in enhanced surfactant gene expression.
a-d, Volcano plots of DGE from scRNA-seq analysis of Foxn1-Cre(+)/Runx1+/+ (WT) mice and Foxn1-Cre(+)/Runx1fl/fl (KO) mice for Ccl21alow (a), Late Aire (b), Keratinocyte-like mTECs (c), and M cell mTECs (d). e, Confocal images of SFTPC (green), DCLK1 (red), and DAPI (blue) from the thymus of Foxn1-Cre (-)/Runx1fl/fl (Cre(-)) and Foxn1-Cre(+)/Runx1fl/fl (Cre(+)) mice. Images taken at 63X magnification. Scale bars = 25 μm. f, Confocal images of SFTPC (green), KRT10 (red), and DAPI (blue) from the thymus of Cre(-) and Cre(+) mice. Images taken at 190X magnification. Scale bars = 15 μm. g-i, Violin plots of chemokine gene expression from scRNA-seq. (a-d) Differentially expressed genes in volcano plots were determined using a two-sided Wilcoxon rank-sum test. (e,f) Data are representative of three independent experiments.
Extended Data Fig. 6 Runx1-deletion in TECs does not alter SP or DP thymocyte populations.
a, Flow cytometry and percentage/absolute number of thymic single positive (SP) CD4+ T cells, SP CD8+ T cells, double positive (DP) T cells, and double-negative (DN) T cells from 30-day-old Foxn1-Cre(-)/Runx1fl/fl mice (Cre(-)) and Foxn1-Cre(+)/Runx1fl/fl mice (Cre(+)) (n = 8 mice; two independent experiments). b, Flow cytometry of B220−/Nk1.1−/TCRγδ−/CD25−/CD5+/TCRβ+ signaled and B220−/Nk1.1−/TCRγδ−/CD25−/CD5−/TCRβ− non-signaled T cells Cre(-), Cre(+), and Foxn1-Cre(+)/Ikzf1fl/fl (Ikzf1fl/fl) mice (n = 3 Cre(-), n = 5 Cre(+), and n = 2 Ikzf1fl/fl mice; two independent experiments). c, H&E staining of the lacrimal gland, and salivary gland. Scale bars = 500 μm. Bar graphs quantitate lymphocytic infiltrate (n = 5 Cre(-) and n = 4 Cre(+) mice). d, Merged UMAP of scRNA-seq data from Foxn1-Cre(+)/Runx1fl/fl (Cre(+)) mTECs, Aire WT mTECs, and Aire−/− mTECs. Approximately 12,000 mTECs were sequenced for both the Aire WT and Aire−/− datasets. e, Overlay of cells from each genotype on the merged UMAP. Red numbers represent the percentage of AT2 mTECs in each genotype. f, Bar graphs representing the percentage of mimetic cells found in Aire WT vs Aire−/− mTECs. (a-c) In graphs, the bars correspond to the mean, with error bars showing ±SD of values shown, and each data point represents an individual mouse. (a-b) P values by unpaired two-tailed t-test. (c) P value by two-tailed nonparametric Mann Whitney.
Extended Data Fig. 7 Runx1 suppresses EGFR-induced genes in TECs.
a, Location of Runx1 binding sites relative to the transcriptional start site (TSS) from GREAT (Genomic Regions Enrichment of Annotations Tool). b, Motif analysis of Runx1 binding sites from CUT&RUN using MEME-ChIP (Motif Analysis of Large Nucleotide Datasets). The top 5 motifs identified in CUT&RUN were Runx motifs. c, Metascape analysis of genes increased in Runx1-deficient mTECs from scRNA-seq DGE expression comparing total mTECs (all mTEC clusters combined) from Foxn1-Cre(+)/Runx1+/+ (WT) mice versus Foxn1-Cre(+)/Runx1fl/fl (KO) mice. d, Overlay of EGFR-induced genes on scRNA-seq DGE expression comparing total mTECs (all mTEC clusters combined) in WT mice versus KO mice. Blue numbers represent the number of EGFR induced genes in WT mTECs and red numbers represent the number of EGFR induced genes in KO mTECs. e, Overlay of EGFR-induced genes from specific timepoints on scRNA-seq DGE expression comparing total mTECs from WT mice versus KO mice. Blue numbers represent the number of EGFR induced genes in WT mTECs and red numbers represent the number of EGFR induced genes in KO mTECs at each of the indicated timepoints. f-h, Merged genome browser tracks for duplicate CUT&RUN data for IgG, Runx1, and H3K27ac at growth factor receptor gene loci. (d-e) Differentially expressed genes in volcano plots were determined using a two-sided Wilcoxon rank-sum test.
Extended Data Fig. 8 Runx1 binds to ERK-MAPK, mTOR and JAK-STAT gene loci.
a, Merged genome browser tracks for duplicate CUT&RUN data for IgG, Runx1, and H3K27ac at ERK-MAPK gene loci. b, Heatmap of gene expression for total mTECs (all mTEC clusters combined) from Foxn1-Cre(+)/Runx1+/+ (WT) mice versus Foxn1-Cre(+)/Runx1fl/fl (KO) mice for select ERK-MAPK genes in (a). c, Merged genome browser tracks for duplicate CUT&RUN data for IgG, Runx1, and H3K27ac at gene loci for negative regulators of mTOR. d, Heatmap of gene expression for total mTECs (all mTEC clusters combined) from Foxn1-Cre(+)/Runx1+/+ (WT) mice versus Foxn1-Cre(+)/Runx1fl/fl (KO) mice for negative regulators of mTOR and PI3K. e, Merged genome browser tracks for duplicate CUT&RUN data for IgG, Runx1, and H3K27ac at JAK-STAT gene loci. f, Merged genome browser tracks for duplicate CUT&RUN data for IgG, Runx1, and H3K27ac at gene loci for negative regulators of JAK-STAT. g, Heatmap of gene expression for total mTECs (all mTEC clusters combined) from Foxn1-Cre(+)/Runx1+/+ (WT) mice versus Foxn1-Cre(+)/Runx1fl/fl (KO) mice for positive regulators (Jak1/Il6st) and negative regulators of JAK-STAT (Pias/Socs/Ptpn).
Extended Data Fig. 9 Thymic growth factor and growth factor receptor expression.
a, UMAP of thymic CD45− cells (epithelial, mesenchymal, endothelial) from multiple timepoints (Day 3, Day 7, Day 14) of neonatal development. b, Heatmap of marker gene expression for epithelial, mesenchymal, and endothelial populations. c, UMAPs of marker genes for epithelial, mesenchymal, and endothelial populations. d-g, UMAPs and average gene expression for (d) Igf1r, (e) Fgfr2, (f) Igf2, and (g) Fgf10 in cTECs, mTECs, fibroblasts, and endothelial cells.
Extended Data Fig. 10 AT2 mTECs expand in juvenile Foxn1-Cre(+)/Runx1fl/fl/CBG mice and can develop through an Aire-expressing stage or independently of Aire.
a-c, Flow cytometry and percentage of GFP+ mTECs from Foxn1-Cre(+)/Runx1fl/fl/CBG mice (Cre(+)/CBG) at the indicated timepoints (n = 2 (Day 1), n = 2 (Day 4), n = 4 (Day 7), n = 4 (Day 30), and n = 2 (Day 140); two independent experiments). d-f, Flow cytometry and percentage of MHC-IIhigh and MHC-Illow mTECs in Foxn1-Cre(-)/Runx1fl/fl/CBG mice (Cre(-)/CBG) mTECs and Foxn1-Cre(+)/Runx1fl/fl/CBG mice (Cre(+)/CBG) mice at the indicated timepoints. g, IGV CUT&RUN tracks for the indicated genes. h, Cre(-)/CBG mice were treated with EGF for either two or three weeks and flow cytometry was performed for GFPlow and GFPhigh AT2 mTEC (n = 5 mice treated with vehicle for 2 weeks, n = 5 mice treated with EGF for 2 weeks, n = 2 mice treated with vehicle for 3 weeks, and n = 3 mice treated with EGF for 3 weeks; two independent experiments). i, Flow cytometry (left) and percentage and absolute number (right) of GFP+ mTECs from 30-day-old Cre(-)/CBG and Foxn1-Cre(+)/Runx1+/fl/CBG mice (Het/CBG) 21 days after irradiation and treated with EGF or Vehicle for three weeks (n = 1 vehicle-treated Cre(-)/CBG, n = 2 EGF-treated Cre(-)/CBG, n = 1 vehicle-treated Het/CBG, and n = 1 EGF-treated Het/CBG mice; representative experiment). j, Cre(-)/CBG mice were treated with EGF for three weeks and qPCR of AT2 marker genes was performed on sort purified GFPlow, GFPhigh, and a control population (GFPneg) (n = 3 mice; representative experiment). k, qPCR of Runx1 gene expression from sorted MHC-IIlow mTECs from Foxn1-Cre(-)/Runx1fl/fl mice (Cre(-)/Runx1fl/fl), Foxn1-Cre(+)/Runx1+/fl mice (Cre(+)/Runx1+/fl), and Foxn1-Cre(+)/Runx1fl/fl mice (Cre(+)/Runx1fl/fl) (n = 4 Cre(-)/Runx1fl/fl, n = 2 Cre(+)/Runx1+/fl, and n = 2 Cre(+)/Runx1fl/fl mice; representative experiment). l-m, Flow cytometric analysis of CD11c−/CD45−/EpCAM+/Ly51−/tdtTmt+/GFP+ mTECs from (l) Aire-CreERT2/R26tdTomato/ Runx1+/fl (CBG(-)) mice or (m) Aire-CreERT2/R26tdTomato/Runx1+/fl/ CBG (CBG(+)) mice treated with tamoxifen and EGF for two weeks (lineage trace). n, Flow cytometry (left) and percentage and absolute number (right) of GFP+ mTECs from 30-day-old Het/CBG mice treated with IGF2 or Vehicle for two weeks (n = 2 mice; representative experiment). (h,j) In graphs, the bars correspond to the mean, with error bars showing ±SD of values shown, and each data point represents an individual mouse. (h,j) Statistical significance was calculated using a one-way ANOVA, and grouped comparisons were corrected using Tukey’s multiple comparison test.
Supplementary information
Supplementary Information (download PDF )
Supplementary Figs. 1 and 2.
Supplementary Table 1 (download PDF )
Table of reagents used.
Supplementary Table 2 (download PDF )
List of RUNX1 target genes.
Source data
Source Data Fig. 1 (download XLSX )
Statistical source data.
Source Data Fig. 2 (download XLSX )
Statistical source data.
Source Data Fig. 3 (download XLSX )
Statistical source data.
Source Data Fig. 4 (download XLSX )
Statistical source data.
Source Data Fig. 5 (download XLSX )
Statistical source data.
Source Data Fig. 7 (download XLSX )
Statistical source data.
Source Data Extended Data Fig. 1 (download XLSX )
Statistical source data.
Source Data Extended Data Fig. 2 (download XLSX )
Statistical source data.
Source Data Extended Data Fig. 6 (download XLSX )
Statistical source data.
Source Data Extended Data Fig. 10 (download XLSX )
Statistical source data.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Sin, J.H., Bowman, C.J., Germino, J. et al. Thymic alveolar type 2 epithelial mimetic cells revealed by RUNX1 deficiency. Nat Immunol (2026). https://doi.org/10.1038/s41590-026-02536-0
Received:
Accepted:
Published:
Version of record:
DOI: https://doi.org/10.1038/s41590-026-02536-0


